GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pluri Inc (NAS:PLUR) » Definitions » Shiller PE Ratio

Pluri (PLUR) Shiller PE Ratio : (As of Apr. 12, 2025)


View and export this data going back to 1991. Start your Free Trial

What is Pluri Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Pluri Shiller PE Ratio Historical Data

The historical data trend for Pluri's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pluri Shiller PE Ratio Chart

Pluri Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Pluri Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Pluri's Shiller PE Ratio

For the Biotechnology subindustry, Pluri's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pluri's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pluri's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Pluri's Shiller PE Ratio falls into.


;
;

Pluri Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Pluri's E10 for the quarter that ended in Dec. 2024 is calculated as:

For example, Pluri's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-0.53/133.1571*133.1571
=-0.530

Current CPI (Dec. 2024) = 133.1571.

Pluri Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201503 -8.000 99.621 -10.693
201506 -5.600 100.684 -7.406
201509 -5.600 100.392 -7.428
201512 -4.000 99.792 -5.337
201603 -7.200 100.470 -9.542
201606 -6.400 101.688 -8.381
201609 -6.400 101.861 -8.366
201612 -6.400 101.863 -8.366
201703 -7.200 102.862 -9.321
201706 -5.600 103.349 -7.215
201709 -6.400 104.136 -8.184
201712 -6.400 104.011 -8.193
201803 -0.800 105.290 -1.012
201806 -7.200 106.317 -9.018
201809 -6.160 106.507 -7.701
201812 -6.000 105.998 -7.537
201903 -6.880 107.251 -8.542
201906 -4.160 108.070 -5.126
201909 -3.680 108.329 -4.523
201912 -3.200 108.420 -3.930
202003 -3.360 108.902 -4.108
202006 -2.560 108.767 -3.134
202009 -2.640 109.815 -3.201
202012 -3.920 109.897 -4.750
202103 -3.840 111.754 -4.575
202106 -3.680 114.631 -4.275
202109 -2.880 115.734 -3.314
202112 -2.720 117.630 -3.079
202203 -2.480 121.301 -2.722
202206 -2.240 125.017 -2.386
202209 -1.520 125.227 -1.616
202212 -1.920 125.222 -2.042
202303 -1.520 127.348 -1.589
202306 -1.200 128.729 -1.241
202309 -0.960 129.860 -0.984
202312 -0.960 129.419 -0.988
202403 -1.010 131.776 -1.021
202406 -1.070 132.554 -1.075
202409 -1.080 133.029 -1.081
202412 -0.530 133.157 -0.530

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Pluri  (NAS:PLUR) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Pluri Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Pluri's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pluri Business Description

Traded in Other Exchanges
Address
MATAM Advanced Technology Park, Building No.5, Haifa, ISR, 3508409
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.
Executives
Lorne Kenneth Abony director MATAM PARK, BUILDING #5, HAIFA L3 3508409
Zami Aberman officer: Chief Executive Officer 63 RABUTZKY STREET, RAANANA L3 43220
Varda Shalev director MATAM PARK, BUILDING #5, HAIFA L3 3508409
Pinhas Doron Birger director MATAM PARK, BUILDING #5, HAIFA L3 3508409
Clover Wolf Capital - Limited Partnership 10 percent owner BOODENHIMER 24, TEL AVIV L3 6200838
Rami Avraham Levi director MATAM ADVANCED TECHNOLOGY PARK, BUILDING NO. 5, HAIFA L3 3508409
Maital Shemesh-rasmussen director MATAM ADVANCED TECHNOLOGY PARK, BUILDING NO. 5, HAIFA L3 3508409
Doron Shorrer director 33 KOREH PLADORR ST, JERUSALEM L3 93393
Isaac Braun director 9 ZEHARIA STREET, BENE BARAK L3 51540
Yaky Yanay officer: Chief Financial Officer ARGAMAN 14, SHIMSHIT L3 17906
Moria Kwiat director HAKFAR 11, KIRYAT ONO L3 55525
Israel Ben-yoram director 24 BARKAN STREET, RISHON LEZION L3 00000
Chen Franco-yehuda officer: Chief Financial Officer MATAM ADVANCED TECHNOLOGY PARK, BUILDING NO. 5, HAIFA L3 31905
Mark Germain director WELLSFORD REAL PROPERTIES INC, 535 MADISON AVENUE, NEW YORK NY 10022
Erez Egozi officer: Chief Financial Officer MATAM PARK, BUILDING 05, HAIFA L3 31905